Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetically decreased vitamin D and risk of Alzheimer disease.

Neurology - 13 Dec 2016

Mokry Lauren E, Ross Stephanie, Morris John A, Manousaki Despoina, Forgetta Vincenzo, Richards J Brent

Abstract excerpt

OBJECTIVE: To test whether genetically decreased vitamin D levels are associated with Alzheimer disease (AD) using mendelian randomization (MR), a method that minimizes bias due to confounding or reverse causation. METHODS: We selected single nucleotide polymorphisms (SNPs) that are strongly associated with 25-hydroxyvitamin D (25OHD) levels (p < 5 × 10-8) from the Study of Underlying Genetic Determinants of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Canada
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Osteoporosis

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Vitamin D

Source

Open in PubMed Open full text

Identifiers

PMID: 27856775
DOI: 10.1212/WNL.0000000000003430
PMCID: PMC5207000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetically decreased vitamin D and risk of Alzheimer disease.PMID 27856775Read ↗

Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer's Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

Circulating Vitamin D Levels and Alzheimer’s Disease: A Mendelian Randomization Study in the IGAP and UK BiobankSemantic proximity Read ↗

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

The impact of plasma vitamin C levels on the risk of cardiovascular diseases and Alzheimer's disease: A Mendelian randomization study.Semantic proximity Read ↗

The causal role of circulating vitamin D concentrations in human complex traits and diseases: a large-scale Mendelian randomization studySemantic proximity Read ↗

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.Semantic proximity Read ↗

The causal role of circulating vitamin D concentrations in human complex traits and diseases: a large-scale Mendelian randomization study.Semantic proximity Read ↗

Investigation of the causal relationship between osteocalcin and dementia: A Mendelian randomization studySemantic proximity Read ↗

Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study.Semantic proximity Read ↗

Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study.Semantic proximity Read ↗

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

Genetically increased serum calcium levels reduce Alzheimer’s disease riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.